Ann Wilson’s health concerns forces Heart to postpone all tour dates

Heart has postponed the remainder of its 2024 North American tour due to Ann Wilson’s continued health challenges.

In late May, the band canceled European tour dates due to what was described as a “time-sensitive but routine medical procedure.” A statement reads:

Dear friends, I underwent an operation to remove something that, as it turns out, was cancerous. The operation was successful and I’m feeling great but my doctors are now advising me to undergo a course of preventive chemotherapy and I’ve decided to do it. And so my doctors are instructing me to take the rest of the year away from the stage in order to fully recover. To the ticket buyers, I really do wish we could do these gigs. Please know that I absolutely plan to be back on stage in 2025. My team is getting those details sorted and we’ll let you know the plan as soon as we can. Thank you all for the support. This is merely a pause. I’ve much more to sing. Respectfully, this is the last public statement I’d like to make on the matter. Fans are encouraged to hold onto their tickets, as they will be honored for the rescheduled dates. More information to be announced in the coming weeks.

Heart kicked up the Royal Flush Tour in April alongside Cheap Trick. This was the band’s first extended tour since 2019. The tour was supposed to extend until late September. The European detour came to a halt in June and July. Heart was supposed to perform with Def Leppard and Journey at stadium shows in July and August. Last summer, Nancy Wilson revealed that Heart was working on new music inspired by the band’s legendary late-’70s work. Their most recent album, “Beautiful Broken”, was released in 2016, but both Wilson sisters have also recorded solo albums since then.